In addition to smoking cessation and regular influenza vaccination, pharmacotherapy is used to treat COPD patients. Long-acting bronchodilators are central to COPD therapy since they reduce patient symptoms such as dyspnea, facilitate an increase in physical activity, and prevent disease exacerbation. The severity of COPD is determined according to the patient's dyspnea, exercise capacity, physical activity, and exacerbation frequency. Pulmonary rehabilitation and drug therapy are effective for facilitating increases in the physical activity of COPD patients.
|Number of pages||9|
|Journal||Japanese Journal of Chest Diseases|
|Publication status||Published - 2013|
- Physical activity
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine